Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Liquid Handling Platform

By Drug Discovery Trends Editor | March 18, 2010

zinsserDealing with membrane proteins in lipidic mesophases is not an easy task. Until now the sample preparation has been a very tedious and time-consuming task.

Zinsser Analytic has developed ProCrys Meso, the new liquid handling platform for the preparation of 96 in-meso (or cubic phase) proteins. It offers accurate and precise dispensing of the protein and the screening solution and also can be used to prepare your own screening solutions on the workbench instead of using the more expensive commercial kits. An integrated module ensures the ideal humidity conditions for the process. Clever tools have been incorporated to set up a run more easily, including precise and reproducible dispensing of the mesophase.

ProCrys Meso is based on a 1 meter liquid handling platform with 2 pipetting arms. The first pipetting arm is equipped with pipetting probes for the preparation of the screening solutions and its distribution to the crystallization plate. The second arm is used for the transfer of the nanoliter volumes of the protein solution. The protein and the screening solution, as well as the crystallization plate are placed on the workbench.

The WinProCrys software allows maximum flexibility of method development. Work lists can be imported from Excel® or the customer’s LIMS system.

ProCrys Meso not only increases the throughput and the reproducibility of the experiments, it also reduces costs.

ZINSSER ANALYTIC GMBH


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50